We are sad to report that Kathryn will not qualify to participate in the Neridronate study this summer because one of the meds she has used for the last 2 years is not yet out of her system.
However, she is in line to participate later in 2015 or early 2016.
Her pain is very high right now so, since she cannot participate in the study this summer, we are planning Ketamine treatments soon. A 6 week period is required between Ketamine and drug study participation but her pain is too high to delay Ketamine any further.
Along with other clinicians, researchers and CRPS patients and their families, we plan to petition the company who is handling the Neridronate study to ask them to eliminate this particular medication as a disqualifier.
(I apologize for not giving the name of the company or the drug, but that seems best at this time.)
Prayer requests:
- For God’s will and faithful help
- That this drug company eliminates this medication as a disqualifier
- That Kathryn is able to participate in the study soon and does not get the placebo
- That this or another treatment becomes available soon for CRPS
- For relief for all those who suffer with chronic pain
Kathryn's Pages 